"
Team:Potsdam Bioware
From 2012.igem.org
(→Direct Antibody Identification, Maturation and Production in CHO-Cells) |
|||
| Line 1: | Line 1: | ||
| + | <div class="box_round"> | ||
{| style="color:#1b2c8a;background-color:#0c6;" border="1" bordercolor="#fff" width="62%" align="center" | {| style="color:#1b2c8a;background-color:#0c6;" border="1" bordercolor="#fff" width="62%" align="center" | ||
!align="center"|[[Team:Potsdam_Bioware|Home]] | !align="center"|[[Team:Potsdam_Bioware|Home]] | ||
| Line 11: | Line 12: | ||
!align="center"|[[Team:Potsdam_Bioware/Attributions|Attributions]] | !align="center"|[[Team:Potsdam_Bioware/Attributions|Attributions]] | ||
|} | |} | ||
| - | + | </div> | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
==Direct Antibody Identification, Maturation and Production in CHO-Cells== | ==Direct Antibody Identification, Maturation and Production in CHO-Cells== | ||
Revision as of 21:14, 24 August 2012
| Home | Team | Official Team Profile | Project | Parts Submitted to the Registry | Modeling | Notebook | Safety | Attributions |
|---|
Direct Antibody Identification, Maturation and Production in CHO-Cells
Project Description
Antibodies are versatile molecules for research and therapy and they are currently revolutionizing the market of biopharmaceuticals. To date, antibodies are generated in a laborious and time consuming manner. Either animal immunization followed by hybridoma technology or phage display is used to identify desired genes, which then need to be transferred to a production cell line such as CHO. We designed a streamlined workflow that incorporates all steps of antibody generation in CHO cells. Our plan is to stably transfect an antibody-fragment library in CHO cells. Antibody maturation is mimicked by further diversifying this library using the enzyme Activation-Induced cytidine Deaminase (AID), which is known to induce somatic hypermutation. Next, we plan to test and deploy a versatile and continuous viral selection system for clones producing the desired antibodies. Finally, we will try to employ a genetic switch to go from surface expression to soluble production of antibodies.
| Home | Team | Official Team Profile | Project | Parts Submitted to the Registry | Modeling | Notebook | Safety | Attributions |
|---|
